NSAID Labeling Revisions Revised Again In Response To Industry Comments
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised template for OTC nonsteroidal anti-inflammatory drugs drops the “longer than 10 days” use timeframe in the cardiovascular risk warning in exchange for “long term continuous use.” New supplemental labeling request restarts six-month clock for firms to revise labeling.